Study to Evaluate Smecta® vs Placebo on the Time to Recovery Following an Acute Diarrhoea Episode in Adults
Launched by IPSEN · Jan 12, 2006
Trial Information
Current as of May 19, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Acute diarrhoea episode defined as at least 3 watery stools per day for 48 hours or less
- • Patient with, usually, normal bowel habits, i.e. at least 3 stools per week and no more than 3 stools per day
- Exclusion Criteria:
- • Gross blood, pus in the stools
- • Fever \>39ºC
- • Other episode of acute watery diarrhoea within the last 30 days
- • History of chronic diarrhoea or motor diarrhoea
About Ipsen
Ipsen is a global biopharmaceutical group dedicated to innovation and specialty care, focusing on the discovery, development, and commercialization of transformative medicines for patients with serious diseases. With a strong emphasis on oncology, neuroscience, and rare diseases, Ipsen leverages cutting-edge research and advanced technologies to deliver high-quality therapies that address unmet medical needs. Committed to scientific excellence and ethical practices, Ipsen collaborates with healthcare professionals and stakeholders to drive patient-centered solutions and improve health outcomes worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Casablanca, , Morocco
Casablanca, , Morocco
Casablanca, , Morocco
Casablanca, , Morocco
Casablanca, , Morocco
Casablanca, , Morocco
Rabat, , Morocco
Ben Arous, , Tunisia
La Marsa, , Tunisia
Menzel Bourguiba, , Tunisia
Monastir, , Tunisia
Nabeul, , Tunisia
Sfax, , Tunisia
Sousse, , Tunisia
Sousse, , Tunisia
Sousse, , Tunisia
Sousse, , Tunisia
Sousse, , Tunisia
Sousse, , Tunisia
Sousse, , Tunisia
Sousse, , Tunisia
Sousse, , Tunisia
Sousse, , Tunisia
Sousse, , Tunisia
Tunis, , Tunisia
Tunis, , Tunisia
Tunis, , Tunisia
Tunis, , Tunisia
Tunis, , Tunisia
Tunis, , Tunisia
Tunis, , Tunisia
Patients applied
Trial Officials
Ipsen Medical Director
Study Director
Ipsen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials